Cargando…
Specific Antibodies and Arachidonic Acid Mediate the Protection Induced by the Schistosoma mansoni Cysteine Peptidase-Based Vaccine in Mice
Several reports have documented the reproducible and considerable efficacy of the cysteine peptidase-based schistosomiasis vaccine in the protection of mice and hamsters against infection with Schistosoma mansoni and Schistosoma haematobium, respectively. Here, we attempt to identify and define the...
Autores principales: | Tallima, Hatem, Abou El Dahab, Marwa, El Ridi, Rashika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712720/ https://www.ncbi.nlm.nih.gov/pubmed/33207535 http://dx.doi.org/10.3390/vaccines8040682 |
Ejemplares similares
-
Role of T lymphocytes and papain enzymatic activity in the protection induced by the cysteine protease against Schistosoma mansoni in mice
por: Tallima, Hatem, et al.
Publicado: (2019) -
Increased hepatic interleukin-1, arachidonic acid, and reactive oxygen species mediate the protective potential of peptides shared by gut cysteine peptidases against Schistosoma mansoni infection in mice
por: Tallima, Hatem, et al.
Publicado: (2023) -
Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase
por: Tallima, Hatem, et al.
Publicado: (2017) -
Arachidonic Acid Is a Safe and Efficacious Schistosomicide, and an Endoschistosomicide in Natural and Experimental Infections, and Cysteine Peptidase Vaccinated Hosts
por: Tallima, Hatem, et al.
Publicado: (2020) -
Is arachidonic acid an endoschistosomicide?
por: Hanna, Violette Said, et al.
Publicado: (2018)